Crystallization of 25-Hydroxy-7-dehydrocholesterol Purification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The existing methods for synthesizing 25-hydroxy-vitamin D3 are plagued by high levels of impurities, specifically 3β-Cholesta-5,7,22-triene-3,25-diol, which are difficult to separate due to their similar physical properties, leading to contamination in the final product.

Innovation Solution

A crystallization process using a solvent system comprising ethanol, 1-propanol, or 2-propanol, with a minimum 50% weight percentage, effectively separates 25-Hydroxy-7-dehydrocholesterol from its impurity by exploiting differences in their solubility and crystallization behavior.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional synthesis methods are used to produce 25-hydroxy-vitamin D3, then the production process can proceed, but high levels of impurities (3β-Cholesta-5,7,22-triene-3,25-diol) remain difficult to separate

Engineering Contradiction:
Improvepurity of 25-hydroxy-vitamin D3VSAvoidcomplexity of separation process
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent applies parameter changes by modifying the physical state and solubility characteristics of the compounds through controlled crystallization. By adjusting temperature, solvent composition, and crystallization conditions, the method exploits subtle differences in solubility parameters between compound (I) and impurity (II) to achieve separation. This transforms the separation problem from a complex multi-step process into a controlled phase transition process.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The core invention utilizes phase transitions through crystallization. Compound (I) is induced to crystallize from solution while impurity (II) remains in the mother liquor. The phase transition from dissolved state to crystalline solid state allows for physical separation via filtration, effectively removing the impurity without requiring complex separation equipment or multiple processing steps.

Inventive Principle:
Principle #36Phase transitions

2Manufacturing precision

If repetitive reduction reaction cycles are used as disclosed in US 4,116,985, then cholesta-5,7-diene-3β-25-diol can be isolated, but the process becomes very laborious and expensive

Engineering Contradiction:
Improvepurity of cholesta-5,7-diene-3β-25-diolVSAvoidefficiency of synthesis process
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The invention applies preliminary action by performing crystallization early in the synthesis pathway, immediately after the formation of compound (I). This single preliminary purification step removes impurity (II) before subsequent photochemical reactions, preventing impurity propagation throughout the entire synthesis sequence. This eliminates the need for repetitive reduction cycles performed in prior art.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The method extracts impurity (II) from the reaction mixture through selective crystallization of compound (I). By exploiting solubility differences, the impurity is left in the mother liquor while the desired compound crystallizes out. The crystallized product is then separated by filtration, effectively extracting the pure compound from the impure reaction mixture in a single operation.

Inventive Principle:
Principle #2Taking out (Extraction)

3Productivity

If compound of formula (II) is present in high amounts, then the synthesis can proceed, but the impurity is transformed analogously to an impurity in the targeted end product HyD

Engineering Contradiction:
Improverate of synthesisVSAvoidpurity of end product HyD
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The invention applies preliminary anti-action by removing impurity (II) through crystallization before the photochemical transformation step. This preemptive purification prevents the impurity from being converted into unwanted byproducts in the final product. By eliminating the impurity source early, the method ensures high purity in the end product without requiring additional purification steps after photochemical reaction.

Inventive Principle:
Principle #9Preliminary anti-action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method significantly reduces the impurity levels in 25-Hydroxy-7-dehydrocholesterol, achieving purities of less than 0.07% by weight in a single crystallization step, with further recrystallization cycles enhancing purity while maintaining high yields.

Implementation Method 1

A crystallization using a unique solvent system can offer a solution to said problem... exploiting differences in their solubility and crystallization behavior

Methodology Applied
Scientific EffectSolubility difference: Solvation

Implementation Method 2

crystallization of compound of formula (I) from a composition comprising the compound of formula (I) and the compound of formula (II)

Methodology Applied
Scientific EffectCrystallization: Crystallisation

Data Source

PatentEP3383885B1Crystallization of 25-hydroxy-7-dehydrocholsterol
Publication Date: 2021.10.13 DSM IP ASSETS BV
  • EP3383885B1 patent drawing
  • EP3383885B1 patent drawing
  • EP3383885B1 patent drawing

AI summary

The present invention relates to a method of purification of compound of formula (I) which comprises the step of crystallization of compound of formula (I) from a composition comprising the compound of formula (I) and the compound of formula (II) and a specific solvent system containing ethanol, 1-propanol, 2-propanol, 2-methyl-1-propanol, 1-butanol or 2-butanol.